Sit Investment Associates Inc. continued to hold its stake in shares of Monsanto Co. (NYSE:MON) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,000 shares of the company’s stock at the end of the second quarter. Sit Investment Associates Inc.’s holdings in Monsanto were worth $310,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of MON. Edmond DE Rothschild Holding S.A. increased its position in Monsanto by 3.2% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,850 shares of the company’s stock valued at $426,000 after buying an additional 150 shares during the last quarter. Meeder Asset Management Inc. increased its position in Monsanto by 1,962.5% in the first quarter. Meeder Asset Management Inc. now owns 8,250 shares of the company’s stock valued at $724,000 after buying an additional 7,850 shares during the last quarter. State Street Corp increased its position in Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock valued at $1,634,002,000 after buying an additional 173,201 shares during the last quarter. OMERS ADMINISTRATION Corp increased its position in Monsanto by 6.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 679,300 shares of the company’s stock valued at $59,602,000 after buying an additional 43,100 shares during the last quarter. Finally, Canada Pension Plan Investment Board increased its position in Monsanto by 1,769.4% in the first quarter. Canada Pension Plan Investment Board now owns 942,942 shares of the company’s stock valued at $82,734,000 after buying an additional 892,500 shares during the last quarter. 79.02% of the stock is owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded up 0.09% during midday trading on Thursday, reaching $102.41. The company’s stock had a trading volume of 1,454,883 shares. The firm has a market capitalization of $44.82 billion, a P/E ratio of 34.27 and a beta of 1.19. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26. The company’s 50-day moving average is $104.66 and its 200 day moving average is $101.70.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.19) earnings per share. Analysts expect that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. Monsanto’s dividend payout ratio (DPR) is 71.05%.
A number of brokerages have recently issued reports on MON. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Monsanto in a report on Thursday, June 30th. Monness Crespi & Hardt cut their price target on Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a report on Monday, October 3rd. Zacks Investment Research downgraded Monsanto from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Finally, BMO Capital Markets reiterated an “outperform” rating and issued a $128.00 price target on shares of Monsanto in a report on Saturday, October 8th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Monsanto currently has an average rating of “Buy” and a consensus target price of $114.65.
In other news, EVP Steven Mizell sold 310 shares of the stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles S. Mcmillan bought 3,500 shares of the firm’s stock in a transaction dated Monday, October 10th. The shares were acquired at an average price of $103.23 per share, with a total value of $361,305.00. Following the purchase, the director now directly owns 64,009 shares of the company’s stock, valued at approximately $6,607,649.07. The disclosure for this purchase can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.